UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer

Journal of cancer research and clinical oncology, 2020-03, Vol.146 (3), p.631-645

2020

Volltextzugriff (PDF)

467 A real-world retrospective study of immunotherapy in NSCLC patients with KRAS mutation

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A521-A521

2023

Volltextzugriff (PDF)

Mining GEO and TCGA Database for Immune Microenvironment of Lung Squamous Cell Carcinoma Patients With or Without Chemotherapy

Frontiers in oncology, 2022-02, Vol.12, p.835225-835225

2022

Volltextzugriff (PDF)

Effective low-dose Anlotinib induces long-term tumor vascular normalization and improves anti-PD-1 therapy

Frontiers in immunology, 2022-08, Vol.13, p.937924-937924

2022

Volltextzugriff (PDF)

Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell lung cancer patients with negative PD-L1 expression: A network meta-analysis

Frontiers in oncology, 2022-11, Vol.12, p.1001503-1001503

2022

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Mutation Status and Response to Tyrosine Kinase Inhibitors in Advanced Chinese Female Lung Squamous Cell Carcinoma: A Retrospective Study

Frontiers in oncology, 2021-04, Vol.11, p.652560-652560

2021

Volltextzugriff (PDF)

Anti-angiogenic therapy or immunotherapy? A real-world study of patients with advanced non-small cell lung cancer with EGFR/HER2 exon 20 insertion mutations

Frontiers in oncology, 2024-03, Vol.14, p.1357231-1357231

2024

Volltextzugriff (PDF)

Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non‐small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line therapy

Clinical and translational medicine, 2023-06, Vol.13 (6), p.e1277-n/a

2023

Volltextzugriff (PDF)

Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.643-652

2021

Volltextzugriff (PDF)

Impact of PD-L1 expression on the efficacy of first-line crizotinib in advanced ROS1-rearranged NSCLC

Lung cancer (Amsterdam, Netherlands), 2024-08, Vol.194, p.107892, Article 107892

2024

Volltextzugriff (PDF)

Atorvastatin suppressed proliferation and facilitated apoptosis of A549 cells through mediating recruitment of Fas and CD59 in lipid raft

Tropical journal of pharmaceutical research, 2022-02, Vol.21 (2), p.237-244

2022

Volltextzugriff (PDF)

Special issue “The advance of solid tumor research in China”: Real‐world clinical outcomes of alectinib for advanced nonsmall‐cell lung cancer patients with ALK fusion in China

International journal of cancer, 2023-01, Vol.152 (1), p.15-23

2023

Volltextzugriff (PDF)

Design and Practice of Communication System During EDL for Mars Probe

Mobile Wireless Middleware, Operating Systems and Applications, p.234-246

Volltextzugriff (PDF)

Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: a retrospective study

Lung cancer (Amsterdam, Netherlands), 2020-08, Vol.146, p.244-251

2020

Volltextzugriff (PDF)

Treatment efficacy of HER2-mutant lung adenocarcinoma by immune checkpoint inhibitors: a multicenter retrospective study

Cancer Immunology, Immunotherapy, 2022-07, Vol.71 (7), p.1625-1631

2022

Volltextzugriff (PDF)

EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled Study

Clinical lung cancer, 2021-05, Vol.22 (3), p.e395-e404

2021

Volltextzugriff (PDF)

Anlotinib Combined with Anti‐PD1 Potentiates Anti‐Tumor Immunity via Immunogenic Cell Death and Macrophage Reprogramming

Advanced therapeutics, 2023-11, Vol.6 (11)

2023

Volltextzugriff (PDF)

A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab

Translational lung cancer research, 2022-08, Vol.11 (8), p.1619-1630

2022

Volltextzugriff (PDF)

Pembrolizumab monotherapy or combination therapy for bone metastases in advanced non-small cell lung cancer: a real-world retrospective study

Translational lung cancer research, 2022-01, Vol.11 (1), p.87-99

2022

Volltextzugriff (PDF)

Special issue "The advance of solid tumor research in China": Real-world clinical outcomes of alectinib for advanced non-small-cell lung cancer patients with ALK fusion in China

International journal of cancer, 2022-05

2022

Volltextzugriff (PDF)

Design and verification of the multinode and multisystem relay communication system for the Tianwen-1 Mars Probe

SCIENTIA SINICA Technologica, 2022-02, Vol.52 (2), p.226-236

2022

Volltextzugriff (PDF)

Design and verification of multiple-probe-combination integrated TT&C and data transmission subsystem

SCIENTIA SINICA Technologica, 2021-08, Vol.51 (8), p.873-885

2021

Volltextzugriff (PDF)

First‐line pemetrexed/carboplatin or cisplatin/bevacizumab compared with paclitaxel/carboplatin/bevacizumab in patients with advanced non‐squamous non‐small cell lung cancer with wild‐type driver genes: A real‐world study in China

Thoracic cancer, 2019-05, Vol.10 (5), p.1043-1050

2019

Volltextzugriff (PDF)

Design and verification of relay communication system for lunar farside exploration

SCIENTIA SINICA Technologica, 2019-02, Vol.49 (2), p.147-155

2019

Volltextzugriff (PDF)

Research on Tianwen-1 Mars Probe Relay Communication Technology

Mobile Wireless Middleware, Operating Systems and Applications, p.222-233

Volltextzugriff (PDF)

1 – 25 von 216

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(191)

Publikationsform

Sprache

Englisch
(216)

Erscheinungsjahr

n.n

Thema

Science & Technology
(169)
Life Sciences & Biomedicine
(109)
Technology
(45)
Humans
(43)
Materials Science
(29)
Female
(28)
Oncology
(27)
Materials Science, Multidisciplinary
(26)
Cotton
(25)
Physical Sciences
(24)
Engineering
(20)
Male
(20)
Plant Sciences
(20)
Adult
(18)
Animals
(18)
Middle Aged
(18)
Science & Technology - Other Topics
(17)
Chemistry
(15)
Agriculture
(13)
Genotypes
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer

467 A real-world retrospective study of immunotherapy in NSCLC patients with KRAS mutation

Mining GEO and TCGA Database for Immune Microenvironment of Lung Squamous Cell Carcinoma Patients With or Without Chemotherapy

Effective low-dose Anlotinib induces long-term tumor vascular normalization and improves anti-PD-1 therapy

Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell lung cancer patients with negative PD-L1 expression: A network meta-analysis

Epidermal Growth Factor Receptor Mutation Status and Response to Tyrosine Kinase Inhibitors in Advanced Chinese Female Lung Squamous Cell Carcinoma: A Retrospective Study

Anti-angiogenic therapy or immunotherapy? A real-world study of patients with advanced non-small cell lung cancer with EGFR/HER2 exon 20 insertion mutations

Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non‐small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line therapy

Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC

Impact of PD-L1 expression on the efficacy of first-line crizotinib in advanced ROS1-rearranged NSCLC

Atorvastatin suppressed proliferation and facilitated apoptosis of A549 cells through mediating recruitment of Fas and CD59 in lipid raft

Special issue “The advance of solid tumor research in China”: Real‐world clinical outcomes of alectinib for advanced nonsmall‐cell lung cancer patients with ALK fusion in China

Design and Practice of Communication System During EDL for Mars Probe

Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: a retrospective study

Treatment efficacy of HER2-mutant lung adenocarcinoma by immune checkpoint inhibitors: a multicenter retrospective study

EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled Study

Anlotinib Combined with Anti‐PD1 Potentiates Anti‐Tumor Immunity via Immunogenic Cell Death and Macrophage Reprogramming

A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab

Pembrolizumab monotherapy or combination therapy for bone metastases in advanced non-small cell lung cancer: a real-world retrospective study

Special issue "The advance of solid tumor research in China": Real-world clinical outcomes of alectinib for advanced non-small-cell lung cancer patients with ALK fusion in China

Design and verification of the multinode and multisystem relay communication system for the Tianwen-1 Mars Probe

Design and verification of multiple-probe-combination integrated TT&C and data transmission subsystem

First‐line pemetrexed/carboplatin or cisplatin/bevacizumab compared with paclitaxel/carboplatin/bevacizumab in patients with advanced non‐squamous non‐small cell lung cancer with wild‐type driver genes: A real‐world study in China

Design and verification of relay communication system for lunar farside exploration

Research on Tianwen-1 Mars Probe Relay Communication Technology

Suchergebnisse filtern